$145.59 Million in Sales Expected for Sabra Health Care REIT Inc (SBRA) This Quarter

Wall Street analysts predict that Sabra Health Care REIT Inc (NASDAQ:SBRA) will announce $145.59 million in sales for the current quarter, according to Zacks Investment Research. Four analysts have issued estimates for Sabra Health Care REIT’s earnings. The highest sales estimate is $154.03 million and the lowest is $139.82 million. Sabra Health Care REIT reported sales of $166.47 million in the same quarter last year, which would suggest a negative year over year growth rate of 12.5%. The firm is expected to announce its next earnings report after the market closes on Sunday, February 24th.

On average, analysts expect that Sabra Health Care REIT will report full-year sales of $630.09 million for the current fiscal year, with estimates ranging from $624.02 million to $639.46 million. For the next year, analysts forecast that the business will post sales of $596.94 million, with estimates ranging from $566.08 million to $659.19 million. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side analysts that that provide coverage for Sabra Health Care REIT.

SBRA has been the topic of several research analyst reports. BidaskClub upgraded shares of Sabra Health Care REIT from a “sell” rating to a “hold” rating in a research report on Tuesday, January 29th. Raymond James cut shares of Sabra Health Care REIT from an “outperform” rating to a “market perform” rating in a report on Friday, November 16th. ValuEngine cut shares of Sabra Health Care REIT from a “hold” rating to a “sell” rating in a report on Thursday, November 15th. Bank of America lowered shares of Sabra Health Care REIT from a “neutral” rating to an “underperform” rating and cut their target price for the stock from $23.00 to $21.00 in a research report on Friday, November 16th. Finally, Citigroup set a $18.00 price objective on shares of Sabra Health Care REIT and gave the company a “hold” rating in a research report on Tuesday, November 20th. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $21.36.



Hedge funds have recently made changes to their positions in the stock. Renaissance Technologies LLC acquired a new stake in Sabra Health Care REIT in the 3rd quarter worth about $8,186,000. Loomis Sayles & Co. L P grew its holdings in Sabra Health Care REIT by 3.0% during the 3rd quarter. Loomis Sayles & Co. L P now owns 334,875 shares of the real estate investment trust’s stock worth $7,742,000 after acquiring an additional 9,613 shares during the last quarter. Gateway Investment Advisers LLC grew its holdings in Sabra Health Care REIT by 15.9% during the 4th quarter. Gateway Investment Advisers LLC now owns 262,820 shares of the real estate investment trust’s stock worth $4,331,000 after acquiring an additional 36,152 shares during the last quarter. LPL Financial LLC boosted its stake in shares of Sabra Health Care REIT by 7.5% in the 3rd quarter. LPL Financial LLC now owns 186,633 shares of the real estate investment trust’s stock valued at $4,315,000 after purchasing an additional 13,062 shares during the last quarter. Finally, Riverhead Capital Management LLC boosted its stake in shares of Sabra Health Care REIT by 38.8% in the 3rd quarter. Riverhead Capital Management LLC now owns 31,837 shares of the real estate investment trust’s stock valued at $736,000 after purchasing an additional 8,900 shares during the last quarter. 92.52% of the stock is owned by institutional investors and hedge funds.

Shares of NASDAQ SBRA traded down $0.05 during trading on Wednesday, hitting $20.51. The company had a trading volume of 1,479,100 shares, compared to its average volume of 1,637,679. The stock has a market capitalization of $3.70 billion, a P/E ratio of 8.46, a P/E/G ratio of 2.47 and a beta of 1.02. Sabra Health Care REIT has a 52 week low of $15.70 and a 52 week high of $23.83. The company has a debt-to-equity ratio of 1.00, a quick ratio of 2.88 and a current ratio of 2.88.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, February 28th. Stockholders of record on Friday, February 15th will be given a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a dividend yield of 8.78%. The ex-dividend date of this dividend is Thursday, February 14th. Sabra Health Care REIT’s dividend payout ratio (DPR) is presently 74.07%.

Sabra Health Care REIT Company Profile

As of September 30, 2018, Sabra's investment portfolio included 487 real estate properties held for investment (consisting of (i) 350 Skilled Nursing/Transitional Care facilities, (ii) 91 Senior Housing communities (“Senior Housing – Leased”), (iii) 24 Senior Housing communities operated by third-party property managers pursuant to property management agreements (“Senior Housing – Managed”) and (iv) 22 Specialty Hospitals and Other facilities), one investment in a direct financing lease, 22 investments in loans receivable (consisting of (i) one mortgage loan, (ii) two construction loans, (iii) one mezzanine loan, (iv) one pre-development loan and (v) 17 other loans), 11 preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing – Managed communities.

Featured Article: No Load Funds

Get a free copy of the Zacks research report on Sabra Health Care REIT (SBRA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply